The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

ASH 2018 AML Challenges in Evaluating New Therapies: Understanding the Recent FDA Approvals

181 views
March 19, 2019
Comments 0
Login to view comments. Click here to Login